Hervé Tilly

MYC-IG rearrangements are negative predictors of survival in DLBCL patients treated with immunochemotherapy: a GELA/LYSA study

Christiane Copie‐Bergman, Peggy Cuillière-Dartigues, Maryse Baia et al. · Blood · 2015 · 254 citations · Full text

Life Sciences, Immunology, Oncology +12

Molecular Profile and FDG-PET/CT Total Metabolic Tumor Volume Improve Risk Classification at Diagnosis for Patients with Diffuse Large B-Cell Lymphoma

Anne‐Ségolène Cottereau, Hélène Lanic, Sylvain Mareschal et al. · Clinical Cancer Research · 2016 · 186 citations

Medicine, Hematology, Oncology +17

Comparison of High-Dose Therapy and Autologous Stem-Cell Transplantation With Conventional Therapy for Hodgkin's Disease Induction Failure: A Case-Control Study

Marc André, M. Henry‐Amar, José-Luis Pico et al. · Journal of Clinical Oncology · 1999 · 154 citations

Medicine, Hematology, Oncology +15

Detection and prognostic value of recurrent exportin 1 mutations in tumor and cell-free circulating DNA of patients with classical Hodgkin lymphoma

Vincent Camus, Aspasia Stamatoullas, Sylvain Mareschal et al. · Haematologica · 2016 · 118 citations · Full text

Medicine, Hematology, Oncology +17

Prognostic value of baseline total metabolic tumor volume (TMTV0) measured on FDG-PET/CT in patients with peripheral T-cell lymphoma (PTCL)

Anne‐Ségolène Cottereau, Stéphanie Becker, Florence Broussais et al. · Annals of Oncology · 2016 · 113 citations · Full text

Medicine, Nuclear Medicine, Oncology +14